CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 39,506 shares (option exercise)
- 4 Open-market buy Director bought 58,357 shares at an average $2.37 ($138,225)
- 4 Open-market buy Director bought 40,215 shares at an average $2.37 ($95,355)
- 4 Open-market sale Director sold 25,000 shares at an average $11.10 ($277,622)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $10.79 ($80,926)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $9.02 ($67,675)
- 4 Open-market sale President and COO sold 25,000 shares at an average $9.03 ($225,665)
Page 9 of 22 · 436 filings